Posted: July 17, 2007
For a long time now, consultants with a vested interest -- ie, financial interest -- in eMarketing have repeatedly cherry-picked data to support the notion that Big Pharma is on the verge of shifting massive amounts of marketing dough to online venues.
The latest "Annual DTC Industry Checkup" survey published by Dendrite is a case in point. The press release "DTC Marketing for U.S. Prescription Drugs Moves Online" makes a remarkable claim based on cherry picking data from the survey.
There are several other non-online trends I could pick from this survey.
To find out what these other cherries are, see today's post to Pharma Marketing Blog.
For more posts in related topic areas, see:
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
| Return to Pharma Marketing Blog Topics |